Shuqiang Yuan

9PUBLICATIONS
31CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsGene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 05, 2026
Perioperative Toripalimab Plus Chemotherapy Versus Chemotherapy Alone in Locally Advanced Gastric or Gastroesophageal Junction Cancer: 3-Year Follow-Up of NEOSUMMIT-01 Trial.

|Apr 23, 2026
Neoadjuvant toripalimab plus CapeOX in locally advanced Epstein-Barr virus-associated gastric or gastroesophageal junction adenocarcinoma: a phase Ⅱ trial.

|Jan 25, 2025
Application of Spatial Transcriptomics in Digestive System Tumors.

Bowen Huang, Yingjia Chen, Shuqiang Yuan

|Dec 30, 2024
Transcriptional landscape and predictive potential of long noncoding RNAs in peritoneal recurrence of gastric cancer.

Xiao-Xia Cai, Guo-Ming Chen, Zi-Qi Zheng

|Nov 13, 2024
CAF-macrophage crosstalk in tumour microenvironments governs the response to immune checkpoint blockade in gastric cancer peritoneal metastases.

Yuanfang Li, Yongqiang Zheng, Jiaqian Huang

|Jan 08, 2024
Author Correction: Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial.

Shu-Qiang Yuan, Run-Cong Nie, Ying Jin

Pageof 2

Frequent Collaborators

5 joint publications

Run-Cong Nie

4 joint publications

Mu-Yan Cai

4 joint publications

Feng Wang

3 joint publications

Ji-Bin Li